TORISEL is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma. (1) The recommended dose of TORISEL is 25 mg administered as an intravenous infusion over a 30–60 minute period once a week. Treat until disease progression or unacceptable toxicity. (2.1) TORISEL injection, 25 mg/mL supplied with DILUENT for TORISEL. (3)

Temsirolimus, sold under the brand name Torisel, is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in May 2007, [3] and was also approved by the European Medicines Agency (EMA) in November 2007. [1]

Aug 23, 2023 · Torisel is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Torisel is used to treat cancer of the kidneys, also called renal cell carcinoma. Torisel may also be used for purposes not listed in this medication guide.

TORISEL is administered as an intravenous infusion over a 30- to 60-minute period once weekly. The use of an infusion pump is the preferred method of administration to ensure accurate delivery of the product.

Find TORISEL® medical information: Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Visit www.torisel.com. Pfizer Oncology Together™ provides financial assistance resources to help patients access their prescribed Oncology medicines. TORISEL - U.S. Medical Information Page - patient information, ways to contact Pfizer Medical & other resources; for Healthcare professionals: TORISEL U.S. Physician Prescribing Information

Mar 25, 2025 · TORISEL ® is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma. (1) The recommended dose of TORISEL is 25 mg administered as an intravenous infusion over a 30–60 minute period once a week. Treat until disease progression or unacceptable toxicity. (2.1) TORISEL injection, 25 mg/mL supplied with DILUENT for TORISEL. (3)

TORISEL is an inhibitor of mTOR approved in the European Union for the first-line treatment of patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors. TORISEL demonstrated a statistically significant increase in median overall survival (OS) compared with IFN-α.

Medscape - Renal cell carcinoma dosing for Torisel (temsirolimus), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...

Feb 16, 2020 · What is Torisel used for? Torisel is used to treat kidney cancer. Torisel may be given to you for other reasons. Talk to your doctor. If you are allergic to Torisel; any part of this medicine; or any other drugs, foods, or substances. Tell your doctor about the allergy and what signs you had. If you have a high bilirubin level or liver problems.